Home▸Lung Cancer Treatment▸PD-L1 Checkpoint-Inhibitor Eligibility Simulator

🫁 PD-L1 Checkpoint-Inhibitor Eligibility Simulator

The interactive selector determines the eligibility for pembrolizumab based on the level of PD-L1 (Tumor Proportion Score) expression on tumor cells as a biomarker of response to immunotherapy.

Lung Cancer Treatment2DModerate60 FPS

⚙ Under the hood

The interactive selector determines the eligibility for pembrolizumab based on the level of PD-L1 (Tumor Proportion Score) expression on tumor cells as a biomarker of response to immunotherapy.

CanvasBiomedicine

2D · HTML5 Canvas 2D · 60 FPS target · runs fully client-side, no install